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Background: Long-term exposure to traffic-related air pollution may increase blood pressure (BP) 
and induce hypertension. However, evidence supporting these associations is limited, and they 
may be confounded by exposure to traffic noise and biased due to inappropriate control for use of 
BP-lowering medications.
oBjectives: We evaluated the associations of long-term traffic-related air pollution with BP and 
prevalent hypertension, adjusting for transportation noise and assessing different methodologies to 
control for BP-lowering medications.
Methods: We measured systolic (SBP) and diastolic BP (DBP) at baseline (years 2003–2005) in 
3,700 participants, 35–83 years of age, from a population-based cohort in Spain. We estimated 
home outdoor annual average concentrations of nitrogen dioxide (NO2) with a land-use regression 
model. We used multivariate linear and logistic regression.
results: A 10-μg/m3 increase in NO2 levels was associated with 1.34 mmHg (95% CI: 0.14, 
2.55) higher SBP in nonmedicated individuals, after adjusting for transportation noise. Results 
were similar in the entire population after adjusting for medication, as commonly done, but weaker 
when other methods were used to account for medication use. For example, when 10 mmHg were 
added to the measured SBP levels of medicated participants, the association was β = 0.78 (95% CI: 
–0.43, 2.00). NO2 was not associated with hypertension. Associations of NO2 with SBP and DBP 
were stronger in participants with cardiovascular disease, and the association with SBP was stronger 
in those exposed to high traffic density and traffic noise levels ≥ 55 dB(A).
conclusions: We observed a positive association between long-term exposure to NO2 and SBP, 
after adjustment for transportation noise, which was sensitive to the methodology used to account 
for medication.
citation: Foraster M, Basagaña X, Aguilera I, Rivera M, Agis D, Bouso L, Deltell A, Marrugat J, 
Ramos R, Sunyer J, Vila J, Elosua R, Künzli N. 2014. Association of long-term exposure to 
traffic-related air pollution with blood pressure and hypertension in an adult population–based 
cohort in Spain (the REGICOR study). Environ Health Perspect 122:404–411; http://dx.doi.
org/10.1289/ehp.1306497
Introduction
Air pollution may not only trigger cardio­
vascular events but promote chronic patholo­
gies and subsequent cardiovascular disease 
(CVD) (Pope and Dockery 2006), which 
would further contribute to cardiovascular 
mortality (Brook et al. 2010). This is sup­
ported by animal studies (Brook et al. 2010) 
and associations between long­term expo­
sure to air pollutants and markers of athero­
sclerosis (Künzli et al. 2011). Long­term 
exposure to air pollution may also contribute 
to CVD through high blood pressure (BP), 
an established determinant of athero genesis 
and CVD, and a leading cause of death 
(Lopez et al. 2006). Given the ubiquity of 
air pollution, identifying the association with 
high BP is important for public health.
There is increasing evidence that short­
term exposure to air pollution (i.e., hours to 
months) is positively associated with systolic 
BP (SBP) and/or diastolic BP (DBP) levels, 
although there exists some heterogeneity in 
previous studies (Brook et al. 2010, 2011; 
Chuang et al. 2010; Delfino et al. 2010). 
Less is known about long­term exposure. 
Four cross­sectional studies in population­
based samples, the elderly, or men reported 
significant positive associations of annual 
average home outdoor concentrations of 
different pollutants with BP (Chuang et al. 
2011; Dong et al. 2013; Fuks et al. 2011; 
Schwartz et al. 2012). In contrast, another 
cross­sectional study in a population­based 
sample reported inverse associations with 
SBP (Sørensen et al. 2012). Regarding the 
prevalence and incidence of hypertension, 
the few studies available provide inconsistent 
evidence (Coogan et al. 2012; Dong et al. 
2013; Fuks et al. 2011; Johnson and Parker 
2009; Sørensen et al. 2012). Plausible bio­
logical pathways involve autonomic nervous 
system imbalance, oxidative stress and sys­
temic inflammation, and subsequent endo­
thelial dysfunction (Brook et al. 2009; Mills 
et al. 2008).
Several studies suggest that near­road 
traffic­related air pollution—indicated by 
resi dential proximity to traffic—could be 
particularly important for CVD (e.g., Brook 
et al. 2009; Hoffmann et al. 2007; Künzli 
et al. 2010). Traffic­related air pollution 
could also be relevant for BP (Schwartz et al. 
2012). Traffic is also a main source of noise, 
which has been associated with hypertension 
in the long­term (van Kempen and Babisch 
2012), and may potentially confound or 
modify the effects of air pollution on BP. 
However, few studies have adjusted for it 
(Fuks et al. 2011; Sørensen et al. 2012).
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A particular challenge and weakness of 
previous publications relates to dealing with 
BP­lowering medication. Conceptually, air 
pollution would lead to high BP and, sub­
sequently to treatment and lower BP levels. 
Thus, treatment would be a mediator, not 
a confounder, of the measured BP levels 
in those taking BP­lowering medication. 
Therefore, the common procedure of adjust­
ing for medication may introduce bias, as pre­
viously suggested (Fuks et al. 2011; Schwartz 
et al. 2012; Tobin et al. 2005).
The purpose of this cross­sectional study 
was to evaluate the association of home out­
door estimates of annual average concentra­
tions of nitrogen dioxide (NO2), a marker of 
traffic­related air pollution, with SBP, DBP, 
and the prevalence of hypertension, adjust­
ing for traffic­related noise and particularly 
evaluating different procedures to account 
for BP­lowering medication. Furthermore, 
we investigated whether residential proximity 
to main roads, exposure to high traffic noise 
levels, and different population characteristics 
modified the association between pollution 
and BP. We capitalized on the large and well­
defined adult population of the REGICOR 
(Registre Gironí del Cor) cohort studies 
conducted in Girona, Spain.
Methods
Study population. The study population 
consisted of 3,836 individuals, 35–83 years 
of age, who participated at baseline (years 
2003–2006) in one of the population­based 
cohorts of the REGICOR project, described 
elsewhere (Grau et al. 2007). Briefly, we ran­
domly selected potential participants from all 
noninstitutionalized inhabitants of the city 
of Girona. From those, 73.8% attended the 
baseline visit. Girona is a typical mid sized 
Mediterranean urban area of nearly 100,000 
inhabitants in the northeast of Spain, with 
a densely populated center where traffic is 
expected to be the main contributor to air 
pollution levels. The study was approved by 
Hospital del Mar Research Institute ethics 
committee, and participants signed written 
informed consent.
Outcomes  and health as se s sment . 
Participants fasted for 10 hr before examina­
tion. Trained nurses performed the exami­
nations from 0800 to 1100 hours. BP was 
measured at the beginning, following the 
Joint National Committee VII recommen­
dations (Chobanian et al. 2003), in sitting 
position, and with a calibrated automatic 
device (OMRON 711; Omron Healthcare, 
Lake Forest, IL, USA) that also registered 
heart rate. The first and second measurements 
were done after at least 10 and 3 min of rest, 
respectively. If measurements differed by 
≥ 5 mmHg, a third measurement was taken. 
To avoid “white coat effect,” we used the last 
measurement available. The nurses also with­
drew blood to obtain cholesterol, triglyceride, 
and fasting glucose levels.
We collected individual questionnaire 
information on smoking, weekly leisure time 
physical activity (based on the Minnesota 
Leisure­time Physical Activity Questionnaire) 
(Elosua et al. 2000), daily alcohol intake, liv­
ing alone, family history of cardiovascular 
deaths, diet (defined with the REGICOR 
score for adherence to Mediterranean diet) 
(Schröder et al. 2004), educational level, 
and occupational status. In addition, we 
assessed socioeconomical status (SES) with 
the deprivation index at the census tract level 
(Domínguez­Berjón and Borrell 2005). We 
defined diabetes as fasting blood glucose level 
≥ 126 mg/dL or reported treatment with anti­
diabetic drugs, body mass index (BMI) as 
weight/height squared (kilograms per meter 
squared), and cardiovascular disease as having 
ever had a cardiovascular event (myocardial 
infarction or stroke) or cardiovascular­related 
surgery intervention.
We defined hypertension as having SBP 
or DBP ≥ 140 or 90 mmHg (Chobanian 
et al. 2003), respectively, or as taking anti­
hypertensive treatment, reported with a posi­
tive response to the question “Do you take or 
have you taken any doctor­prescribed medica­
tion to reduce blood pressure in the last two 
weeks?” For BP analysis, we accounted for 
any “BP­lowering medication.” It included 
anti hypertensive treatment, as defined with 
the question above, or the use of any treat­
ment from the medication list provided by 
participants and coded by a physician as “anti­
hypertensive” or “beta­blocker” [i.e., diuretics, 
ACE (angiotensin­converting­enzyme) inhibi­
tors, alpha­ or beta­blockers, angiotensin recep­
tor II blockers, and calcium channel blockers].
We used two alternative definitions of 
hypertension in sensitivity analyses to evalu­
ate the potential misclassification of cases: 
a) We considered the antihypertensive­like 
treatment of the medication list in the hyper­
tension definition instead of the self­reported 
antihypertensive treatment described above, 
and b) we excluded participants with BP levels 
close to the cut­off value for hypertension 
(i.e., we excluded nonmedicated participants 
with SBP and DBP ≥ 135/85 mmHg and 
< 150/95 mmHg). Besides, we defined “hyper­
tension or prehypertension,” which included 
both hypertensives and prehypertensives, as 
cases. Prehypertensives are commonly classi­
fied as nonhypertensive and are not medicated; 
however, they have nonoptimal BP levels (i.e., 
SBP or DBP ≥ 120/80 mmHg but below 
the cut­off for hypertension) (Chobanian 
et al. 2003) that could be influenced by 
air pollution.
Exposure assessment. We geocoded partici­
pants’ residential addresses at enrollment. 
We estimated annual average outdoor NO2 
(micrograms per cubic meter) at the resi­
dences with a city­specific land use regression 
(LUR) model (R2 = 0.63) based on a dense 
network of residential outdoor NO2 measure­
ments (years 2007–2009), as described else­
where (Rivera et al. 2013). The main predictor 
variables were the height of the sampler and 
traffic­related variables at different radius 
 buffers (from 25 to 1,000 m) around the 
 sampling locations.
To control for acute effects of short­term 
air pollution and temperature on measured 
BP, we obtained daily means of tempera­
ture and of NO2 concentrations at an urban 
background station from the regional air 
quality monitoring network. Season was cate­
gorized as winter (January–March), spring 
(April–June), summer (July–September), and 
autumn (October–December).
We also derived long­term average traffic 
noise levels [A­weighted decibels; dB(A)] 2 m 
from the façades and at the floors’ height of 
each dwelling with a detailed and validated 
city­specific noise model (year 2005). This 
model complies with the European Noise 
Directive 2002/49/EC (END) and uses the 
interim European method NMPB routes­96 
[CERTU (Centre d’Études sur les Réseaux, les 
Transports, l’Urbanisme et les Constructions 
Publiques) et al. 1997]. Estimates were com­
puted at each receptor point by numerical cal­
culations using CadnaA software (DataKustik, 
Greifenberg, Germany). The main input 
variables were street slopes, type of asphalt, 
urban topography, and traffic density. Because 
railway noise has also been associated with 
BP (Dratva et al. 2012), and a single North–
South rail bridge crosses dense traffic areas in 
the city, we also derived residential railway 
noise estimates from an END­based model 
according to the International Organization for 
Standardization (ISO; Geneva, Switzerland) 
standard 9613. The propagation model was 
built upon source identification of railway 
noise. This consisted of daytime and nighttime 
noise measurements of frequencies (in one­
third octave bands) and equivalent levels [in 
dB(A)] of freight and normal trains (a total of 
72 measurements). Measurements were taken 
with a SC­30 sound level meter and a CB­5 
calibrator (CESVA, Barcelona, Spain). Because 
it has been suggested that transportation noise 
may affect cardiovascular health particularly 
during the restorative sleep processes at night­
time (Jarup et al. 2008), we used the nighttime 
(2300–0700 hours) noise indicators (Lnight). 
The small airport located outside the city did 
not affect our study population.
Traffic markers (traffic intensity at the 
nearest road and traffic load within a 500­m 
buffer) were collected using the city road net­
work with linked traffic intensities from local 
registries and traffic (Rivera et al. 2012).
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Statistical analyses. We excluded partici­
pants with missing information (n = 101) on 
the outcomes, exposure, or main model covari­
ates. We assessed bivariate associations with 
Spearman rank correlation between continu­
ous variables, with the chi­square test between 
categorical variables, and with the Kruskal–
Wallis test between continuous and categorical 
variables. We used multivariate linear regres­
sion models for BP and logistic regression for 
hypertension, and performed regression diag­
nostics. The shape of the association between 
NO2 and the outcomes was depicted using 
smooth splines with multivariate generalized 
additive models. Inclusion of covariates was 
based on the hypothesized causal pathway of 
long­term effects of NO2 on BP and current 
evidence (Fuks et al. 2011). We also built satu­
rated models with all covariates univariately 
associated with the outcome and exposure 
(p < 0.2) and performed backward regres­
sion, manually removing the variables with 
the highest p­value one­by­one until estimates 
changed ≥ 20%. If changes were smaller, we 
stopped when all p­values were < 0.1. Finally, 
we assessed the inclusion of potential inter­
mediate variables, co­morbidities, and use of 
different lags for daily temperature and NO2 
levels before examination (lags: 1, 2, 3, and 
the average from 0 to 3 days), compared with 
lag 0 (used by default). Temporal trend (day 
of examination) was also examined to control 
for potential decreasing trends in BP levels over 
the study period due to improved BP manage­
ment. Because the different model specifica­
tions gave similar results (data not shown), 
we present final estimates with the most parsi­
monious model based on background regres­
sion (i.e., a model with the minimum set of 
covariates providing the same point estimates 
as did more complex models), to avoid over­
adjustment and variance inflation. The models 
were adjusted for the following variables: age, 
age squared, sex, living alone, educational level, 
diabetes, BMI, nighttime railway noise, road 
traffic noise, smoking, alcohol consumption, 
deprivation, daily NO2 (lag 0), and tempera­
ture (lag 0). We categorized BMI and intro­
duced a square term for age to meet linearity 
with the outcomes. Nonlinearity was assessed 
a priori with univariate generalized additive 
models, checking splines, and was later tested 
in regression diagnostics.
A main objective of this study was to 
rigorously investigate potential biases related 
to different methodologies used or proposed to 
control for BP­lowering medication. Thus, we 
estimated the effects of NO2 on BP as follows: 
a) restricting analysis to participants not taking 
any BP­lowering medication (i.e., in “non­
medicated”); b) restricting analysis to “medi­
cated” participants; c) ignoring treatment; 
d) adjusting for treatment; e) adding a fixed 
value of mmHg for SBP (+10, 15, and 20) 
and DBP (+5, 10, 15) to those treated; and 
f) using censored normal regression. This 
method models the untreated BP levels assum­
ing they are normally distributed. In the 
medicated participants, the untreated BP levels 
are not observed, but they are assumed to be 
at least as high as the measured levels (right 
censoring). The model effectively assumes that, 
given the covariates, untreated BP levels above 
a certain value have the same distribution in 
medicated and non­medicated participants. 
Methodologies a–d were used for comparison 
with previous literature. Methodologies e and f 
were favored in a comprehensive simulation 
study, but rely on nonmeasurable assumptions 
that might be violated in our study population 
(Tobin et al. 2005).
We assessed effect modification of the 
association between NO2 and BP among 
nonmedicated participants by levels of traf­
fic noise at night [Lnight < 55 dB(A) vs. 
≥ 55 dB(A)], traffic intensity at the nearest 
road, and traffic load within 500 m as binary 
variables cate gorized at the median. We also 
evaluated age, sex, educational level, smoking, 
Mediterranean diet, living alone (a marker of 
uncontrolled hypertension) (Morgado et al. 
2010), diabetes, CVD, and season of exami­
nation (given possibly larger effects in sum­
mer (Fuks et al. 2011; Sørensen et al. 2012). 
Effect modification was tested by adjusting 
for an interaction term (i.e., NO2 × evaluated 
cate gorical variable) and checking its statistical 
significance (i.e., p for interaction) as well as 
the studied association per categories of the 
tested variable. The nonmedicated group was 
of primary interest because the outcome is not 
influenced by BP­lowering medication in these 
participants. For comparison, we further evalu­
ated these interactions in the entire sample, 
using methods e (adding 10–15 mmHg for 
SBP and 5–10 mmHg for DBP to measured 
values) and f (censored regression) to control 
for medication. Finally, we tested whether 
associations for nonmedicated and medicated 
were statistically different by introducing an 
inter action term (BP­lowering medication × 
NO2) in the model using method d) (adjusting 
for treatment).
We also performed sensitivity analyses for 
residential mobility by restricting analyses to 
subjects not moving residence in the preced­
ing 2, 5, and 10 years, and checked the time 
window of exposure by using the average 
NO2 exposure of the preceding 10 years for a 
subset of 2,402 individuals with information 
on residential history.
Estimated effects on BP and hyper tension 
are expressed per 10­μg/m3 increase in NO2 
unless differently specified. We defined 
 statistical significance at an alpha level of 0.05.
Analyses were done using Stata version 12.0 
(StataCorp, College Station, TX, USA) and 
R version 2.12 (http:// www.r­project.org/).
Results
The final sample size consisted of 3,700 indi­
viduals. Participants excluded from the study 
had slightly higher SBP levels, less healthy 
lifestyle, more co­morbidities, and lower 
transportation (i.e., traffic and railway) Lnight 
levels (data not shown).
The characteristics of the study popula­
tion included in the final models are sum­
marized in Table 1 and in the Supplemental 
Material, Table S1. Of all participants, 72.6% 
did not take any BP­lowering medication 
(i.e., nonmedicated group). Nonmedicated 
differed from medicated participants in being 
younger on average (53 vs. 68 years of age, 
respectively) but with similar age ranges 
(35–83 vs. 35–82 years, respectively), hav­
ing lower BP, higher educational level, fewer 
co­morbidities, including a greater proportion 
of women, and smoking and drinking more.
Home outdoor levels of annual average 
NO2, long­term railway Lnight, and traffic 
intensity at the nearest road were similar in 
nonmedicated and medicated. The median 
levels in nonmedicated were 26.4 μg/m3, 
41.4 dB(A), and 1,400 vehicles/day, 
respectively. Nonmedicated participants 
had slightly lower traffic Lnight levels than 
did medicated participants [56.5 dB(A) vs. 
56.9 dB(A), respectively].
The highest correlations of annual 
mean NO2 concentrations were with traffic 
Lnight (r = 0.74) and traffic load within a 
500­m buffer (r = 0.91) (see Supplemental 
Material, Table S2).
A 10­μg/m3 increase in annual average 
NO2 (from now onward, NO2) was associ­
ated with a statistically significant increase of 
1.15 mmHg (95% CI: 0.34, 1.95) in SBP 
in nonmedicated in univariate analysis (data 
not shown) and of 1.34 mmHg (95% CI: 
0.14, 2.55) after full adjustment (Table 2). 
This association was less precise in the group 
of medicated participants (β = 1.19; 95% CI: 
–1.37, 3.75). The association between NO2 
and SBP in the entire population (with and 
without adjustment for BP­lowering treat­
ment) yielded similar results (β = 1.35; 
95% CI: 0.23, 2.47, and β = 1.11; 95% CI: 
–0.03, 2.24, respectively). Models adding a 
fixed value of SBP to medicated participants 
showed smaller estimated effects, steadily 
shrinking toward the null with increasing 
fixed values. No association between NO2 and 
SBP was observed with censored regression. 
The main confounders (i.e., covariates produc­
ing the greatest change in point estimates) of 
the association between NO2 and SBP were 
age, transportation noise (both traffic and 
railway), and daily temperature. Not adjust­
ing for traffic and railway noise resulted in a 
smaller coefficient for NO2 (β = 0.59; 95% 
CI: –0.15, 1.34) (Table 2). As additional 
information, the associations of noise with 
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SBP per 10­dB(A) change in Lnight in the 
model for nonmedicated participants were 
β = –0.94 (95% CI: –2.53, 0.64, p = 0.244) 
(traffic noise) and β = –0.21 (95% CI: –0.63, 
0.21, p = 0.326) (railway noise) (data not 
shown). The addition of heart rate, CVD, 
hyperlipidemia, Mediterranean diet, exercise, 
day of examination, daily temperature, or 
daily NO2 levels at lags other than 0 did not 
affect results (data not shown). The association 
between NO2 and SBP suggested a positive 
linear trend > 20 μg/m3 (see Supplemental 
Material, Figure S1). We identified no 
associations of NO2 with DBP (β = 0.15; 
95% CI: –0.57, 0.88) or hypertension [odds 
ratio (OR) = 0.93; 95% CI: 0.79, 1.1] (see 
Supplemental Material, Tables S3 and S4).
Figure 1 shows the interaction analyses 
for the association between NO2 and SBP 
and DBP, respectively, in nonmedicated 
participants. NO2 was more strongly associ­
ated with SBP among individuals with CVD 
(β = 5.96; 95% CI: 1.85, 10.08) than among 
individuals without (β = 1.17; 95% CI: –0.04, 
2.38), p for interaction = 0.02. With DBP 
there was evidence of an association only 
among individuals with CVD (β = 2.71; 95% 
CI: 0.23, 5.18, p for interaction = 0.03). A 
stronger association between NO2 and SBP 
was also found in those living alone (β = 3.93; 
95% CI: 1.32, 6.55) than for those living with 
more people (β = 1.10; 95% CI: 0.23, 5.18), 
p for interaction = 0.03. NO2 was associated 
with SBP in participants exposed to higher 
traffic levels, particularly to traffic loads above 
the median within 500­m buffer (β = 2.28; 
95% CI: 0.58, 3.97) and not in those exposed 
to lower levels (β = –0.79; 95% CI: –2.73, 
1.15), p for inter action = 0.007. This was also 
the case for individuals exposed to traffic Lnight 
≥ 55 dB(A) (β = 1.82; 95% CI: 0.56, 3.07) 
compared with those exposed to lower noise 
levels (β = –0.39; 95% CI: –2.17, 1.39), p for 
interaction = 0.03. Associations of NO2 with 
SBP and DBP were stronger among partici­
pants whose BP was measured in summer ver­
sus other seasons, and this seasonal interaction 
was statistically significant for DBP only (p for 
interaction = 0.04). Sex, educational level, 
and diabetes (Figure 1), and age, smoking, 
and Mediterranean diet (data not shown) did 
not modify the main associations. Interaction 
analyses showed the same patterns when a 
fixed value of mmHg was added to the mea­
sured BP levels of medicated subjects, or when 
censored regression was used to control for 
medication use (data not shown).Finally, there 
was no statistical evidence of differences in the 
associations for the nonmedicated and medi­
cated groups (Table 2; see also Supplemental 
Material, Table S3) neither with SBP nor with 
DBP (p for interaction = 0.472 and 0.318, 
respectively; interactions not shown).
In a subsample with residential history, 
restricting the sample to nonmovers or using 
10­year average NO2 levels yielded similar 
or slightly smaller increases in BP in non­
medicated participants compared with findings 
for the annual average NO2 levels at the current 
address (see Supplemental Material, Table S5).
Discussion
This is one of few studies to analyze the asso­
ciation between near­road traffic­related air 
pollution and both blood pressure (BP) and 
hypertension, and to control for detailed 
transportation noise information. Moreover, 
in this study we evaluated in detail the influ­
ence on findings of using different methodol­
ogies to control for BP­lowering medication.
This cross­sectional population­based 
study showed a statistically significant asso­
ciation between long­term exposure to 
home outdoor NO2, a widely used marker 
Table 1. Main characteristics of the study population (n = 3,700) with and without stratification by use of 
BP-lowering medication.
Variable
Total 
(n = 3,700)
Medicated 
(n = 2,685)
Nonmedicated 
(n = 1,015) p-Valuea
Continuous variables [median (IQR)]
Systolic blood pressure (mmHg) 125 (26.0) 120 (22.0) 139 (27.0) < 0.001
Diastolic blood pressure (mmHg) 78.0 (13.0) 77.0 (12.0) 81.0 (14.0) < 0.001
Age (years) 57.0 (20.0) 53.0 (17.0) 68.0 (15.0) < 0.001
Deprivation indexb –1.82 (1.28) –1.82 (1.22) –1.81 (1.37) < 0.001
Annual average NO2 levels (μg/m3) 26.6 (11.7) 26.4 (11.6) 26.8 (11.9) 0.837
Traffic Lnight [dB(A)], 2300–0700 hours 56.6 (7.00) 56.5 (7.00) 56.9 (7.10) 0.022
Railway Lnight [dB(A)], 2300–0700 hours 41.2 (15.2) 41.4 (15.0) 41.0 (15.2) 0.056
Daily mean NO2 levels, lag 0 (μg/m3) 32.0 (11.9) 32.0 (11.7) 31.7 (12.6) 0.362
Daily mean temperature, lag 0 (ºC) 14.5 (12.4) 14.3 (12.8) 15.0 (11.7) 0.021
Categorical variables [n (%)]
Hypertension, yes 1,478 (39.9) 565 (21.0) 913 (90.0) < 0.001
Sex, male 1,720 (46.5) 1,203 (44.8) 517 (50.9) 0.001
Body mass index
< 20 135 (3.60) 124 (4.60) 11 (1.10) < 0.001
20–25 1,110 (30.0) 939 (35.0) 171 (16.8)
25.1–30 1,618 (43.7) 1,168 (43.5) 450 (44.3)
> 30 837 (22.6) 454 (16.9) 383 (37.7)
Living alone, yes 413 (11.2) 265 (9.90) 148 (14.6) < 0.001
Educational level
University or similar 1,050 (28.4) 853 (31.8) 197 (19.4) < 0.001
Secondary 1,110 (30.0) 878 (32.7) 232 (22.9)
Primary 1,432 (38.7) 902 (33.6) 530 (52.2)
Illiterate 108 (2.90) 52 (1.90) 56 (5.50)
Smoking
Never smokers 1,881 (50.8) 1,329 (49.5) 552 (54.4) < 0.001
Smokers 811 (21.9) 677 (25.2) 134 (13.2)
Former smokers 1,008 (27.2) 679 (25.3) 329 (32.4)
Diabetes, yes 580 (15.7) 265 (9.90) 315 (31.0) < 0.001
Daily alcohol intake (g/L)
No alcohol 956 (25.8) 630 (23.5) 326 (32.1) < 0.001
Little (< 20) 2,237 (60.5) 1,672 (62.3) 565 (55.7)
Moderate (20.1–39.9) 390 (10.5) 292 (10.9) 98 (9.70)
Excessive (≥ 40) 117 (3.20) 91 (3.40) 26 (2.60)
Cardiovascular disease,c,d yes 269 (7.30) 83 (3.10) 186 (18.5) < 0.001
Abbreviations: IQR, interquartile range. 
aChi-square test and Kruskal–Wallis test for strata of BP-lowering drugs with categorical variables or continuous vari-
ables, respectively. bHigh deprivation corresponds to high values. cMyocardial infarction, ictus, or any cardiovascular 
surgical intervention. dn < 3,700 (< 1% missing observations).
Table 2. Estimated effect of a 10-μg/m3 increase in annual average home outdoor NO2 concentrations 
[β (95% CI)] on SBP (mmHg).
Models for SBPa n Adjusted for noise Unadjusted for noise
Nonmedicated 2,685 1.34 (0.14, 2.55) 0.59 (–0.15, 1.34)
Medicated 1,015 1.19 (–1.37, 3.75) 0.68 (–1.09, 2.44)
Without adjustment for medication 3,700 1.11 (–0.03, 2.24) 0.56 (–0.17, 1.28)
With adjustment for medication 3,700 1.35 (0.23, 2.47) 0.67 (–0.04, 1.38)
+ 10 mmHgb 3,700 0.78 (–0.43, 2.00) 0.41 (–0.36, 1.18)
+ 15 mmHgb 3,700 0.62 (–0.65, 1.89) 0.33 (–0.47, 1.14)
+ 20 mmHgb 3,700 0.46 (–0.88, 1.80) 0.26 (–0.59, 1.11)
Censored regression 3,700 0.38 (–0.98, 1.73) 0.12 (–0.73, 0.97)
aAll multivariate linear regression models were adjusted for age, age squared, sex, living alone, education, diabetes, 
BMI, nighttime railway noise, nighttime traffic noise, smoking, alcohol consumption, deprivation, daily NO2, and tem-
perature (lag 0). Models additionally were adjusted for noise (nighttime railway and traffic noise) and BP-lowering medi-
cation if specified in table. bAddition to SBP for participants with BP-lowering medications. 
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of near­road traffic­related air pollution, 
and SBP among participants not taking 
BP­lowering medication (nonmedicated). 
This association was similar in the entire pop­
ulation whether adjusting or not for medi­
cation, although the latter association was 
slightly weaker. When using methods pro­
posed to better account for medication in the 
entire sample (Tobin et al. 2005)—namely, 
methods e fixed addition and f censored 
regression—the relationship was weaker or 
diluted. Associations were adjusted for expo­
sure to transportation noise, short­term air 
pollution levels, and temperature, and were 
robust to the inclusion of several covariates 
(data not shown). No significant associations 
were generally found for hypertension or 
DBP, although we observed associations with 
DBP in some subgroups of the population.
Blood pressure. The main results for SBP 
are consistent with most of the few studies 
available. Fuks et al. (2011) and Schwartz 
et al. (2012) reported estimated effects with 
urban background particulate matter with 
aerodynamic diameter ≤ 2.5 μg/m3 (PM2.5) 
and black carbon, respectively, but they 
did not analyze NO2. Regarding NO2, one 
study reported inverse associations between 
nitrogen oxides (NOx, NO, and NO2) and 
SBP (Sørensen et al. 2012); a study in China 
reported no association (Dong et al. 2013); 
and a survey of elderly in Taiwan (Chuang 
et al. 2011) reported stronger estimated 
effects than ours, namely a 11.22­mmHg 
increase in SBP (95% CI: 8.56, 13.89) per 
10 μg/m3. Differences among studies may 
reflect different population characteristics 
(e.g., age, ethnicity, lifestyle) or residual con­
founding. Moreover, to the extent that NO2 
may serve as a marker, differences in the air 
pollution mixtures between the study areas 
may also explain the discrepancies.
As reported in two previous epide­
miological studies, there was no association 
between NO2 and DBP (Auchincloss et al. 
2008; Sørensen et al. 2012). Animal and 
human experimental studies suggest that BP 
responses to long­term exposure to air pollu­
tion may be mediated by sustained systemic 
inflammation and/or oxidative stress, impair­
ing endothelial function and increasing BP 
(Brook et al. 2009; Mills et al. 2008). As dis­
cussed by Auchincloss et al. (2008), endothe­
lial dysfunction and subsequent stiffening of 
the aorta would result in increased SBP but 
lower DBP (i.e., increased pulse pressure), 
and subsequent isolated systolic hypertension 
after 60 years of age (Franklin 2006).
Effect of BP-lowering treatment. One of 
the difficulties in studying BP is that anti­
hypertensive medication is a potential media­
tor between air pollution and measured BP 
levels, and not a confounder of the studied 
association. Consequently, the common 
procedures of adjustment for medication may 
introduce bias. Previous studies analyzed non­
medicated participants (Sørensen et al. 2012), 
did not adjust for medication (Chuang et al. 
2011), adjusted for medication (Schwartz 
et al. 2012), or compared models with and 
without adjustment (Fuks et al. 2011). To 
overcome this problem, some methodolo­
gies have been proposed (Tobin et al. 2005). 
However, as discussed below, the latter also 
rely on nonmeasurable assumptions that may 
be violated in some populations.
In the nonmedicated group, we observed 
a statistically significant positive association 
between NO2 and SBP, whereas no associa­
tion was observed between NO2 and BP in 
medicated participants. These results may 
agree with the hypothesis that effects of air 
pollution on BP can be masked by medica­
tion, and that the association might be more 
clearly observed in the nonmedicated group. 
Conditioning (i.e., stratifying) on medication 
can lead to collider stratification bias if air 
pollution is associated with medication, and 
a third factor is associated with both medi­
cation and measured BP. NO2 levels were 
similar in medicated and nonmedicated in 
the entire population (Table 1) and among 
hypertensive participants, a fact that may 
minimize the potential for this bias. The main 
predictors of being nonmedicated but with 
hypertension were being younger and health­
ier, but NO2 was not associated. However, 
younger age, which was associated with lower 
BP levels, also was associated with lower NO2 
levels (Spearman rank r = 0.11, p < 0.001). 
Figure 1. Adjusted β coefficients and 95% CIs for the association of (A) SBP and (B) DBP (mmHg) blood 
pressure with a 10-μg/m3 increase in annual average home outdoor NO2 concentrations by subgroups 
of the population (n = 2,685 nonmedicated participants). Each multivariate linear regression model was 
adjusted for the corresponding interaction term, one at a time, and age, age squared, sex, living alone, 
education, diabetes, BMI, nighttime railway noise, nighttime traffic noise, smoking, alcohol consumption, 
deprivation, daily NO2, and temperature (lag 0). P50, 50th percentile.
*p for interaction < 0.05.
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Although our multivariate models took 
all these factors into account, residual bias 
mediated through age or due to unmeasured 
 characteristics cannot be excluded.
As suggested by Fuks et al. (2011), if air 
pollution leads to high BP, medication intake, 
and subsequent decreases in measured BP lev­
els, and if this is the only mechanism in place, 
then we should observe an inverse association 
between air pollution and measured BP levels. 
However, given the wide range of the popu­
lation studied, different treatments poten­
tially used, and likely diverse compliance 
with treatment, heterogeneity in the treat­
ment effects is expected. This may produce 
not an inverse relationship but a positive but 
underestimated one in medicated participants 
and in the entire population without adjust­
ment for treatment. Under the assumption 
of heterogeneity, medication would also be a 
weaker mediator of the association between 
NO2 and BP, thus resulting in less bias when 
adjusting for medication.
Using a fixed addition of 10 mmHg in 
SBP for those treated led to a positive though 
weaker and not statistically significant asso­
ciation, whereas larger additions showed a 
steady shrinkage of results toward the null. 
As suggested by McClelland et al. (2008), in 
many scenarios the absolute treatment effect 
will depend on the underlying BP levels and 
the target therapeutic values to achieve for 
BP; thus, the simple addition of a fixed value 
would be inadequate. The difference in BP 
levels before treatment and during treatment 
may depend on several characteristics (e.g., 
SES) or unmeasured factors that can in turn 
be associated with exposure. This can also 
bias the results for the fixed addition method. 
Regarding censored regression, one of the 
assumptions of this model is that the distribu­
tion of underlying BP in treated subjects is 
the same as the distribution of measured BP 
in untreated subjects, which might be often 
wrong (Tobin et al. 2005) and not necessarily 
true in our sample. This methodology can 
also underestimate or overestimate the truth 
(McClelland et al. 2008).
In summary, no perfect methodology 
exists to account for BP­lowering medication, 
because all approaches rely on assumptions 
regarding the effect of medication that may 
vary across scenarios and introduce bias. The 
heterogeneity in the treatment effect may 
reduce bias that might be introduced by com­
monly used procedures to account for the 
effect of medication use. In light of the non­
trivial differences in estimated effects across 
the various methods, more studies are needed 
to clarify the complex conceptual challenge we 
raise in this study.
Hypertension. Prevalence of hypertension 
was not associated with annual average NO2 
concentrations in our study. The few previous 
studies found inconsistent results for preva­
lence of hypertension with different pollutants 
(Dong et al. 2013; Fuks et al. 2011; Johnson 
and Parker 2009; Sørensen et al. 2012). 
Regarding incidence of hypertension, no 
association was found in Denmark (Sørensen 
et al. 2012), whereas another study reported an 
increased risk of hypertension that was statisti­
cally significant with long­term NO2 but not 
with PM2.5 (Coogan et al. 2012).
We hypothesized the differences to be 
attributable to misclassification of hyper­
tensive cases, as proposed before (Fuks 
et al. 2011). However, the different defini­
tions of hyper tension yielded all null results 
(see Supplemental Material, Table S4). 
Alternatively, the null associations may 
relate to a loss in statistical power, but also 
of information, when using the binary vari­
able of hypertension. In fact, we observed a 
nonsignificant increased OR when assessing 
prehypertension and hypertension together. 
Prehypertensives are non medicated individu­
als with sub optimal BP levels not reaching 
the cut­off for hypertension. The assessment 
of this group, which has increased CV risk 
(Chobanian et al. 2003), might also be infor­
mative for the effects of air pollution. Results 
considering this nonmedicated group agree 
with results on BP and may explain findings 
among nonmedicated. However, by reclassi­
fying prehypertensive participants, we are par­
tially reclassifying by medication use. Thus, 
as explained for the BP analyses among non­
medicated, residual stratification collider bias 
cannot be excluded.
Transportation noise. Road traffic and rail­
way noise have been associated with high BP 
(Dratva et al. 2012; van Kempen and Babisch 
2012; Sørensen et al. 2011). Therefore, we 
considered transportation noise as a poten­
tial confounder. Although traffic noise and 
NO2 were highly correlated (r = 0.74), the 
negative confounding of transportation noise 
on the studied association with SBP was not 
explained by collinearity among these factors 
[mean variance inflation factor (VIF) for the 
model = 1.45, VIF for NO2 = 3.2, individual 
VIF for road Lnight = 2.25]. We hypothe­
sized that the negative confounding might 
be explained partly by the use of protections 
against noise among participants more exposed 
to noise (e.g., closing windows at night, sleep­
ing in a room facing the backyard). Thus, the 
estimates of outdoor noise may not be suf­
ficient to investigate the independent effects of 
this stressor on BP in our setting. In Girona, 
people live close to traffic, and traffic noise 
is prevalent. Moreover, complaints about 
neighbor hood noise are generally high in 
Spain. Thus, participants may more likely use 
remedies against noise in our study area than in 
settings with less local traffic or different urban 
structures. Protections are expected to affect 
noise exposure to a greater extent than air pol­
lution, because noise propagation depends on 
physical barriers, whereas air pollution dis­
tributes more evenly and its infiltration rates 
are high (Chen and Zhao 2011). Moreover, 
because noise is subject to annoyance, the pro­
tective behavior will more likely correlate with 
noise than air pollution exposure. We consider 
better noise exposure assessment a crucial next 
step to elucidate the role of noise. Thus, we are 
currently developing methods to estimate indi­
vidual exposure to traffic­related noise  levels 
indoors at homes.
Effect modification. We observed a 
stronger positive association between NO2 
and BP in participants with CVD, similar 
to Sørensen et al. (2012), who reported this 
interaction between long­term residential 
NOx and DBP. However, given the small 
numbers in both cases, further studies are 
needed that investigate this interaction. We 
also found a stronger association for partici­
pants living alone. Living alone was strongly 
correlated with being older and exposed to 
slightly higher NO2 levels in our popula­
tion, and Morgado et al. (2010) identified it 
as a predictor of uncontrolled hypertension 
among hypertensives (Morgado et al. 2010).
The association between NO2 and SBP 
was stronger in those more exposed to traf­
fic and road traffic noise [≥ 55dB(A)]. This 
may be attributable to nonlinearity in the 
estimated effects of NO2 on BP. Indeed, 
we observed a null to negative association at 
very low NO2 levels (compared with levels in 
larger Spanish and European cities) and a clear 
positive trend > 20 μg/m3 (see Supplemental 
Material, Figure S1). Our results did not 
change by the use of a quadratic term (data 
not shown), because the nonlinearity was 
observed at very low levels, and our sample 
was distributed across a wider range of NO2 
concentrations. However, the observation 
of nonlinearity may suggest that, at higher 
traffic levels, NO2 may be more representa­
tive of near­road traffic­related pollutants, 
which are particularly associated with CVD 
(Auchincloss et al. 2008; Brook et al. 2009; 
Hoffmann et al. 2007; Künzli et al. 2010). 
In our study areas, low levels of NO2 reflect 
sites with little traffic, so exposure is mostly 
related to urban background pollution; how­
ever, in other urban areas, NO2 is clearly a 
marker for near­road traffic­related pollut­
ants. Similar reasons may explain the negative 
associations observed between SBP and NOx 
in Denmark (Sørensen et al. 2012), where 
many individuals were exposed to particularly 
low NO2 levels (median; 5th–95th percentile: 
16.3; 12.0–32.6, at baseline) compared with 
those in our study area (26.6; 12.6–39.6). 
In addition, the association between NO2 
and SBP tended to the null when adjust­
ing for traffic intensity or traffic load within 
Foraster et al.
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500 m (results not shown), which also sug­
gests that we are observing associations for 
traffic­related air pollution, rather than for 
 background pollution.
Strengths and limitations. The main limi­
tation of this study was its cross­sectional 
design. Our results should be confirmed in 
longitudinal analysis with repeated measures 
of BP and incidence of hypertension.
As in many epidemiological studies, BP 
was measured with standard protocols, con­
sisting in repeated measures taken during one 
single examination, not following clinical pro­
cedures to diagnose hypertension. Although 
results were robust to the different definitions 
of hypertension, and we selected the last BP 
measurement available to minimize the “white­
coat effect,” a residual misclassification of the 
outcome cannot be excluded. Because random 
error in BP measures can be expected, the mis­
classification could likely be nondifferential, 
biasing results toward the null.
Regarding exposure misclassification, we 
assessed individual residential outdoor expo­
sure, not personal exposure. Although people 
spend a relevant part of their time at home, 
as observed in different European areas and 
climates (Schweizer et al. 2007), we cannot 
conclude whether time–activity patterns in 
our population would affect our findings. 
Although our LUR model was developed after 
the study examinations were completed, LUR 
models are good predictors of spatial gradients 
over time (Eeftens et al. 2011). Moreover, no 
major changes in traffic or monitored back­
ground NO2 levels occurred from 2003 to 
2009 (data not shown). Finally, we explored 
whether past exposure influenced the stud­
ied associations with BP levels in a subsample 
with residential history. Although the sub­
sample was not fully representative of the 
study population (slightly younger group with 
lower BP levels), results in this subsample were 
not affected by past residential mobility or by 
using a longer time window of exposure.
Another limitation was the lack of infor­
mation on lead exposure from leaded gaso­
line used before 2000 in Spain. Long­term 
cumulative exposure, reflected by bone lead 
levels, could remain high in this adult popula­
tion and potentially interact with or confound 
the association between NO2 and high BP 
(Schwartz et al. 2011).
As an important strength, we evaluated a 
population­based cohort and a wider age range 
compared with previous study populations, 
some of which had only elderly participants 
(Chuang et al. 2011; Schwartz et al. 2012). 
Thus, our results in the entire population can 
be generalized. Additional strengths include the 
comprehensive analysis of BP­lowering medica­
tion, the use of a LUR model that captured the 
intraurban variability in NO2 levels and that 
allowed individual exposure assessment, and the 
control for many covariates, including detailed 
transportation noise data, which has rarely been 
taken into account in previous literature (Fuks 
et al. 2011; Sørensen et al. 2012).
Conclusions
We observed a positive association between 
long­term exposure to NO2 and SBP in a 
population­based cohort in Girona, after 
adjustment for transportation noise. The asso­
ciation was sensitive to the selected methodol­
ogy to control for BP­lowering medication, 
and was stronger among participants with 
CVD, those living alone, and those exposed 
to more traffic and road traffic noise. These 
results suggest specific effects of near­road 
traffic­related pollutants on BP. High BP 
might be a pathway through which air pol­
lution causes CVD. Although the estimated 
effect size was small, these findings are rel­
evant for public health, given the ubiquity of 
air pollution, which affects millions of people. 
Indeed, a “small” reduction of 2 mmHg in 
the population mean SBP has been estimated 
to result in a 25% reduction in stroke events 
(Girerd and Giral 2004).
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